Search

Venkataraman Balasubramanian

Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1624, 1611
Total Applications
2999
Issued Applications
2017
Pending Applications
254
Abandoned Applications
728

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12637296 [patent_doc_number] => 20180104262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND [patent_app_type] => utility [patent_app_number] => 15/711502 [patent_app_country] => US [patent_app_date] => 2017-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15711502 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/711502
SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND Sep 20, 2017 Abandoned
Array ( [id] => 15432149 [patent_doc_number] => 20200030257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING GALLSTONE SOLUBILIZER FOR TREATMENT OF GALLBLADDER DISEASE [patent_app_type] => utility [patent_app_number] => 16/461785 [patent_app_country] => US [patent_app_date] => 2017-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461785 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/461785
Pharmaceutical composition comprising gallstone solubilizer for treatment of gallbladder disease Sep 18, 2017 Issued
Array ( [id] => 14743799 [patent_doc_number] => 20190255073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS [patent_app_type] => utility [patent_app_number] => 16/333451 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333451 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333451
ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS Sep 14, 2017 Abandoned
Array ( [id] => 12580425 [patent_doc_number] => 20180085304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => OTIC GEL FORMULATIONS FOR TREATING OTITIS EXTERNA [patent_app_type] => utility [patent_app_number] => 15/705101 [patent_app_country] => US [patent_app_date] => 2017-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705101 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/705101
Otic gel formulations for treating otitis externa Sep 13, 2017 Issued
Array ( [id] => 14649317 [patent_doc_number] => 20190231787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => METHODS AND COMPOUNDS FOR TREATING ALCOHOL USE DISORDERS AND ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 16/327803 [patent_app_country] => US [patent_app_date] => 2017-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/327803
METHODS AND COMPOUNDS FOR TREATING ALCOHOL USE DISORDERS AND ASSOCIATED DISEASES Aug 24, 2017 Abandoned
Array ( [id] => 14438973 [patent_doc_number] => 20190177359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID [patent_app_type] => utility [patent_app_number] => 16/326977 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19702 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326977 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/326977
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid Aug 22, 2017 Issued
Array ( [id] => 12091236 [patent_doc_number] => 20170348329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'Combination Drug Therapy' [patent_app_type] => utility [patent_app_number] => 15/684240 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17516 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684240 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/684240
Combination Drug Therapy Aug 22, 2017 Abandoned
Array ( [id] => 12979696 [patent_doc_number] => 20170342103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/681983 [patent_app_country] => US [patent_app_date] => 2017-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 673 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681983 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/681983
3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof Aug 20, 2017 Issued
Array ( [id] => 14372247 [patent_doc_number] => 20190160036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => APPLICATION OF PHOSPHODIESTERASE 4 INHIBITOR ZL-N-91 IN PREPARATION OF MEDICAMENT FOR TREATING PROSTATE CANCER PROLIFERATION AND METASTASIS [patent_app_type] => utility [patent_app_number] => 16/322112 [patent_app_country] => US [patent_app_date] => 2017-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322112 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322112
APPLICATION OF PHOSPHODIESTERASE 4 INHIBITOR ZL-N-91 IN PREPARATION OF MEDICAMENT FOR TREATING PROSTATE CANCER PROLIFERATION AND METASTASIS Aug 7, 2017 Abandoned
Array ( [id] => 16009119 [patent_doc_number] => 20200179402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => MONOHYDROXYLATED 17ALPHA-HYDROXYPROGESTERONE CAPROATE FOR REDUCING CONTRACTILITY [patent_app_type] => utility [patent_app_number] => 16/321965 [patent_app_country] => US [patent_app_date] => 2017-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321965 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321965
MONOHYDROXYLATED 17ALPHA-HYDROXYPROGESTERONE CAPROATE FOR REDUCING CONTRACTILITY Aug 2, 2017 Abandoned
Array ( [id] => 14911075 [patent_doc_number] => 10426837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-01 [patent_title] => Compositions and methods for treating CNS disorders [patent_app_type] => utility [patent_app_number] => 15/660114 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32872 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660114 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/660114
Compositions and methods for treating CNS disorders Jul 25, 2017 Issued
Array ( [id] => 12151510 [patent_doc_number] => 20180022775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/660470 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 45829 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660470 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/660470
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof Jul 25, 2017 Issued
Array ( [id] => 14864599 [patent_doc_number] => 20190282541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 16/318198 [patent_app_country] => US [patent_app_date] => 2017-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318198 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/318198
USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER Jul 19, 2017 Abandoned
Array ( [id] => 14682169 [patent_doc_number] => 20190240199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => TREATMENT FOR GLIOBLASTOMA [patent_app_type] => utility [patent_app_number] => 16/318468 [patent_app_country] => US [patent_app_date] => 2017-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/318468
Treatment for glioblastoma Jul 19, 2017 Issued
Array ( [id] => 12023641 [patent_doc_number] => 20170313739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'TACCALONOLIDE MICROTUBULE STABILIZERS' [patent_app_type] => utility [patent_app_number] => 15/653397 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653397 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/653397
Taccalonolide microtubule stabilizers Jul 17, 2017 Issued
Array ( [id] => 12231866 [patent_doc_number] => 20180064729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Treatment of Pulmonary Disease' [patent_app_type] => utility [patent_app_number] => 15/652777 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16091 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652777 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/652777
Treatment of Pulmonary Disease Jul 17, 2017 Abandoned
Array ( [id] => 12124956 [patent_doc_number] => 20180008543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'Cleavable Lipids' [patent_app_type] => utility [patent_app_number] => 15/651832 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28390 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651832 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/651832
Cleavable Lipids Jul 16, 2017 Abandoned
Array ( [id] => 16007375 [patent_doc_number] => 20200178530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => CRYSTALLINE FORM C OF SHUANGZUOCAOTONG, PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/629879 [patent_app_country] => US [patent_app_date] => 2017-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/629879
Crystalline form C of shuangzuocaotong, preparation method therefor and use thereof Jul 14, 2017 Issued
Array ( [id] => 14883491 [patent_doc_number] => 10421772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Steroids as agonists for FXR [patent_app_type] => utility [patent_app_number] => 15/645136 [patent_app_country] => US [patent_app_date] => 2017-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645136 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/645136
Steroids as agonists for FXR Jul 9, 2017 Issued
Array ( [id] => 14883491 [patent_doc_number] => 10421772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Steroids as agonists for FXR [patent_app_type] => utility [patent_app_number] => 15/645136 [patent_app_country] => US [patent_app_date] => 2017-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645136 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/645136
Steroids as agonists for FXR Jul 9, 2017 Issued
Menu